Compound heterozygous POMGNT1 mutations leading to muscular dystrophydystroglycanopathy type A3: A case report

Dystroglycanopathies, which are caused by reduced glycosylation of alpha-dystroglycan, are a heterogeneous group of neurodegenerative disorders characterized by variable brain and skeletal muscle involvement.